Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Valerie Greene"'
Autor:
Sonisha Warren, Deborah Sampson, Maryam Rahman, Dongjiang Chen, Ashley Ghiaseddin, David Tran, Anne Allen, Valerie Greene, Nagheme Thomas
Publikováno v:
Neuro Oncol
BACKGROUND/OBJECTIVE Tumor treating Fields (TTFields) plus maintenance temozolomide is an approved standard treatment for newly diagnosed Glioblastoma (GBM). TTFields are alternating electric fields of low intensity and intermediate frequency deliver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ee9064367974e58655b2a2067df1c0
https://europepmc.org/articles/PMC6847508/
https://europepmc.org/articles/PMC6847508/
Autor:
Valerie Greene, Maryam Rahman, Sonisha Warren, Ashley Ghiaseddin, Dongjiang Chen, Alexandra Sherman, Deborah Sampson, Annie Allen, David Tran
Publikováno v:
Neuro Oncol
INTRODUCTION Tumor-treating fields (TTFields) are a new standard anti-mitotic treatment for newly diagnosed glioblastoma (ndGBM). Emerging data indicate that TTFields also stimulate innate immunity, leading to adaptive immunity. We hypothesize that i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78e1d26f2388b272e5d73d0bef70fe8
https://doi.org/10.1093/neuonc/noaa215.138
https://doi.org/10.1093/neuonc/noaa215.138
Autor:
Valerie Greene, Gregory J. A. Murad, Sonisha Warren, William A. Friedman, Maryam Rahman, Anthony T. Yachnis, David Tran, Ashley Ghiaseddin, Steven N. Roper, Anne Allen
Prognosis of relapsed glioblastoma (GBM) is dismal and current treatment fails to provide prolonged survival. Small subsets of patients respond well to some novel therapeutics probably due to the genetic variations of tumors and patients. In the Phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a464b062c92858feabd6a4d7bfcc99
https://europepmc.org/articles/PMC6216658/
https://europepmc.org/articles/PMC6216658/
Autor:
Anne Allen, Jian Campian, Valerie Greene, Sonisha Warren, Ashley Ghiaseddin, David Tran, Deborah Sampson, George Ansstas, Stephen Staal
Publikováno v:
Neuro-Oncology. 20:vi1-vi1
Despite aggressive treatment with surgery, radiation therapy and chemotherapy, the median overall survival for recurrent glioblastoma (rGBM) averages 25 weeks. Our prior experience in 8 bevacizumab-refractory GBM patients initially treated with TTFie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8dea2fc79fc1a55f693f100a14f85c
https://doi.org/10.1093/neuonc/noy148.001
https://doi.org/10.1093/neuonc/noy148.001
Autor:
Valerie Greene
'A true story of triumph over tragedy, this book is a must-have guide for anyone affected by stroke.'—William S. Maxfield'Valerie Greene's courage, persistence, and willingness to search for the healing energies within her have shifted her body, mi
Publikováno v:
Journal of Negro Education. Summer2001, Vol. 70 Issue 3, p156. 10p.